tirzepatide discovery Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide - an overview |

Semaglutide treatment significantly improved alanine aminotransferase (ALT) (serum glutamic-pyruvic transaminase [SGPT]) levels, along with reductions in the aspartate aminotransferase to platelet ratio index (APRI) score, liver fat content and liver stiffness

I farmaci per la gestione del diabete sono sempre pi utilizzati anche per la perdita di peso, ma gli studi clinici dimostrano che i pazienti ne interrompono l'assunzione dopo poco tempo

Experts warned that GLP-1 branded supplements don't match the effectiveness of real GLP-1 agonists such Ozempic and Wegovy, medications for diabetes and weight loss.

Semaglutide shows potential kidney-protective benefits beyond weight loss, with studies indicating improved kidney function markers in certain patient populations